Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

[Neuroleptic malignant syndrome (NMS)].

Kishida I, Furuno T, Kawanishi C.

Nihon Rinsho. 2012 Aug;70 Suppl 6:612-5. Japanese. No abstract available.

PMID:
23156583
2.

Dose-dependent effect of antipsychotic drugs on autonomic nervous system activity in schizophrenia.

Iwamoto Y, Kawanishi C, Kishida I, Furuno T, Fujibayashi M, Ishii C, Ishii N, Moritani T, Taguri M, Hirayasu Y.

BMC Psychiatry. 2012 Nov 14;12:199. doi: 10.1186/1471-244X-12-199.

3.

Comparison of prevalence of metabolic syndrome in hospital and community-based Japanese patients with schizophrenia.

Sugawara N, Yasui-Furukori N, Sato Y, Kishida I, Yamashita H, Saito M, Furukori H, Nakagami T, Hatakeyama M, Kaneko S.

Ann Gen Psychiatry. 2011 Sep 12;10:21. doi: 10.1186/1744-859X-10-21.

4.

Prevalence of metabolic syndrome among patients with schizophrenia in Japan.

Sugawara N, Yasui-Furukori N, Sato Y, Umeda T, Kishida I, Yamashita H, Saito M, Furukori H, Nakagami T, Hatakeyama M, Nakaji S, Kaneko S.

Schizophr Res. 2010 Nov;123(2-3):244-50. doi: 10.1016/j.schres.2010.08.030. Epub 2010 Sep 17.

PMID:
20850274
5.

Autonomic nervous system activity and psychiatric severity in schizophrenia.

Fujibayashi M, Matsumoto T, Kishida I, Kimura T, Ishii C, Ishii N, Moritani T.

Psychiatry Clin Neurosci. 2009 Aug;63(4):538-45. doi: 10.1111/j.1440-1819.2009.01983.x. Epub 2009 May 22.

PMID:
19496998
6.

Dopamine D2 receptor gene polymorphisms are associated with suicide attempt in the Japanese population.

Suda A, Kawanishi C, Kishida I, Sato R, Yamada T, Nakagawa M, Hasegawa H, Kato D, Furuno T, Hirayasu Y.

Neuropsychobiology. 2009;59(2):130-4. doi: 10.1159/000213566. Epub 2009 Apr 22.

7.

MAO-A and COMT genotypes as possible regulators of perinatal serotonergic symptoms after in utero exposure to SSRIs.

Hilli J, Heikkinen T, Rontu R, Lehtimäki T, Kishida I, Aklillu E, Bertilsson L, Vahlberg T, Laine K.

Eur Neuropsychopharmacol. 2009 May;19(5):363-70. doi: 10.1016/j.euroneuro.2009.01.006. Epub 2009 Feb 14.

PMID:
19223155
8.

[Drug-induced neuroleptic malignant syndrome].

Kawanishi C, Furuno T, Kishida I.

Nihon Rinsho. 2007 Oct 28;65 Suppl 8:331-5. Review. Japanese. No abstract available.

PMID:
18074558
9.

Unexpectedly high prevalence of akathisia in cancer patients.

Kawanishi C, Onishi H, Kato D, Kishida I, Furuno T, Wada M, Hirayasu Y.

Palliat Support Care. 2007 Dec;5(4):351-4.

PMID:
18044412
10.

Psychiatric assessment of suicide attempters in Japan: a pilot study at a critical emergency unit in an urban area.

Yamada T, Kawanishi C, Hasegawa H, Sato R, Konishi A, Kato D, Furuno T, Kishida I, Odawara T, Sugiyama M, Hirayasu Y.

BMC Psychiatry. 2007 Nov 7;7:64.

11.

Effects of CYP2D6 polymorphisms on neuroleptic malignant syndrome.

Kato D, Kawanishi C, Kishida I, Furuno T, Suzuki K, Onishi H, Hirayasu Y.

Eur J Clin Pharmacol. 2007 Nov;63(11):991-6. Epub 2007 Aug 14.

PMID:
17701031
12.

Monoamine metabolites level in CSF is related to the 5-HTT gene polymorphism in treatment-resistant depression.

Kishida I, Aklillu E, Kawanishi C, Bertilsson L, Agren H.

Neuropsychopharmacology. 2007 Oct;32(10):2143-51. Epub 2007 Feb 14.

13.

Knowledge and attitude towards suicide among medical students in Japan: preliminary study.

Sato R, Kawanishi C, Yamada T, Hasegawa H, Ikeda H, Kato D, Furuno T, Kishida I, Hirayasu Y.

Psychiatry Clin Neurosci. 2006 Oct;60(5):558-62.

PMID:
16958938
14.

Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report.

Kobayashi A, Kawanishi C, Matsumura T, Kato D, Furukawa R, Kishida I, Hirayasu Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):1170-2. Epub 2006 May 8.

PMID:
16682107
15.

First-principles calculations of migration energy of lithium ions in halides and chalcogenides.

Kishida I, Koyama Y, Kuwabara A, Yamamoto T, Oba F, Tanaka I.

J Phys Chem B. 2006 Apr 27;110(16):8258-62.

PMID:
16623504
16.

Neuroleptic malignant syndrome induced by perospirone.

Nakagawa M, Matsumura T, Kato D, Kishida I, Kawanishi C, Tamura K, Hirayasu Y.

Int J Neuropsychopharmacol. 2006 Oct;9(5):635-6. Epub 2005 Nov 29. No abstract available.

PMID:
16313704
17.

CYP2D6 gene deletion allele in patients with neuroleptic malignant syndrome: preliminary report.

Kato D, Kawanishi C, Kishida I, Furuno T, Matsumura T, Hasegawa H, Suzuki K, Hirayasu Y.

Psychiatry Clin Neurosci. 2005 Aug;59(4):504-7.

PMID:
16048458
18.

Delirium resolving upon switching from risperidone to quetiapine: implication of CYP2D6 genotype.

Kato D, Kawanishi C, Kishida I, Furuno T, Matsumura T, Hasegawa H, Hirayasu Y.

Psychosomatics. 2005 Jul-Aug;46(4):374-5. No abstract available.

PMID:
16000684
19.

Association in Japanese patients between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D(2) receptor gene.

Kishida I, Kawanishi C, Furuno T, Kato D, Ishigami T, Kosaka K.

Mol Psychiatry. 2004 Mar;9(3):293-8.

PMID:
15094790
20.

Neuroleptic malignant syndrome induced by donepezil.

Matsumoto T, Kawanishi C, Isojima D, Iseki E, Kishida I, Kosaka K.

Int J Neuropsychopharmacol. 2004 Mar;7(1):101-3. Epub 2004 Jan 20. No abstract available.

PMID:
14731314
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk